Geode Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
|
|||||
|
2025
Q1 | $782K | Buy |
|
|||||
|
2024
Q4 | $333K | Buy |
|
|||||
|
2024
Q3 | $295K | Sell |
|
|||||
|
2024
Q2 | $932K | Buy |
|
|||||
|
2024
Q1 | $1.17M | Buy |
|
|||||
|
2023
Q4 | $1.46M | Buy |
|
|||||
|
2023
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q2 | $1.63M | Sell |
|
|||||
|
2023
Q1 | $16.4M | Buy |
|
|||||
|
2022
Q4 | $20.9M | Buy |
|
|||||
|
2022
Q3 | $19.6M | Buy |
|
|||||
|
2022
Q2 | $20.6M | Buy |
|
|||||
|
2022
Q1 | $1.98M | Buy |
|
|||||
|
2021
Q4 | $2.89M | Buy |
|
|||||
|
2021
Q3 | $634K | Sell |
|
|||||
|
2021
Q2 | $4.37M | Buy |
|
|||||
|
2021
Q1 | $6.64M | Buy |
|
|||||
|
2020
Q4 | $7.65M | Buy |
|